ARLINGTON, Va. — According to the HDA Research Foundation, approximately 94 percent of pharmaceutical sales were completed through health care distributors in 2021. As reported in the 93rd Edition HDA Factbook, sales through traditional healthcare distributors rose by a record-high 9.4 percent to reach $598.7 billion as the COVID-19 pandemic entered its second year. Prescription drugs
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).
ORLANDO — The HDA Research Foundation honors Greg Drew, president of Value Drug Co., with the 2022 Nexus Award for Lifetime Achievement. The Nexus Award, the healthcare distribution industry’s highest individual recognition, was presented last night at the 2022 Business and Leadership Conference here. Since 1956, the Nexus Award has been presented to HDA-member individuals
ORLANDO, Fla. — The Healthcare Distribution Alliance (HDA) recognized nine pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2022 HDA Business and Leadership Conference here. Established in 1959, the DIANA is one of HDA’s highest honors, recognizing manufacturer members for developing innovative new product introductions
ARLINGTON, Va. — HDA recognizes the role health care distributors can play in minimizing the healthcare sector’s carbon footprint. Many members are already committing to sustainability initiatives — from adopting eco-friendly packaging to setting carbon neutrality goals. The efforts of HDA and its membership to enhance the healthcare distribution sector’s sustainability is reflected in HDA’s president
EDISON, N.J. — For HDA member BluPax Pharma, an independently owned and operated distributor of generic pharmaceuticals, relationships are at the core of everything they do. This year, BluPax Pharma celebrates 10 years of strengthening partnerships with manufacturers and providers to bring value, quality and dependability to the healthcare supply chain. Celebrating a Decade of
ARLINGTON, Va. — Updated survey data released today by the HDA Research Foundation indicate that healthcare supply chain partners remain in the formative stages of establishing the interoperable transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) by November 27, 2023. However, some progress has been made since a previous survey
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) applauds the leadership of Senate Health, Education, Labor, and Pensions (HELP) Committee’s Chairwoman Murray (D, Wash.) and Ranking Member Burr (R, N.C.) for introducing the Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act), a bipartisan public health effort to
AUSTIN, Texas — The Healthcare Distribution Alliance (HDA) presented Heather Zenk, president of Supply Chain Operations and Distribution Services, AmerisourceBergen, with the Distribution Management Award for Industry Leadership. The award, which recognizes an individual for their exceptional contributions to the pharmaceutical distribution industry, was presented today at the HDA 2022 Distribution Management Conference in Austin,
AUSTIN, Texas — The Healthcare Distribution Alliance (HDA) honored AmerisourceBergen with the 2022 Distribution Management Award (DMA) in recognition of the company’s collaboration with multiple government and supply chain partners to enable small-practice provider access to the COVID-19 vaccine. The award was presented during the 2022 Distribution Management Conference and Expo in Austin, Texas. The DMA annually recognizes
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement from president and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers”: “HDA has long supported thorough, rigorous and
ARLINGTON, Va. — With the deadline to implement the 2013 Drug Supply Chain Security Act (DSCSA) now less than two years away, HDA has released a new video that highlights the great progress that has been made by industry to implement DSCSA and some of the biggest challenges that still remain. Throughout the implementation process,
ARLINGTON, Va. — The HDA Research Foundation today announces it has awarded graduate-level scholarships to four pharmaceutical supply chain leaders. The program was recently renamed to honor Karen J. Ribler, the Foundation’s former COO who led the organization for nearly 10 years; Ribler passed away in June 2021. “The past few years have proven that
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) announced that Nicolette Louissaint, has been named the organization’s senior vice president of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s executive management team and report to president and chief executive officer Chester “Chip” Davis, Jr. She will join
